ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Paul Conyngham launched Gamgee to offer personalized mRNA cancer vaccines for dogs, backed by Y Combinator. The startup claims a 75% tumor reduction in its first case, though the vaccine was administered alongside another therapy. Gamgee aims to expand to humans.
Tap to vote and see what everyone thinks.
Summary by ByteBrief